Brivaracetam Tablet, Film Coated
Product Images NDC 70771-1756

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 70771-1756). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 01)

FDA Label Image

25 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 02)

25 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 02)
This is a prescription medication named Brivaracetam, which comes in tablet form with each tablet containing 25 mg of the active ingredient. The usual dosage information can be found in the accompanying prescribing information. The package is child-resistant and should be stored at controlled room temperature. A medication guide is available for patients to obtain additional information. The medication is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India.*
FDA Label Image

50 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 03)

50 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 03)
This is information about Brivaracetam tablets containing 50 mg of the active ingredient. The typical dosage and storage instructions are provided, and it emphasizes the importance of keeping the tablets out of the reach of children. A medication guide is also available for more information. The tablets are distributed by 2ydis Lifescences Ltd. in Ahmedabad, India.*
FDA Label Image

75 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 04)

75 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 04)
This text includes information about Brivaracetam tablets, the storage conditions (temperature range between 20°C to 25°C), caution regarding excursions, controlled room temperature requirements, and advice to keep the medication out of reach of children. It also mentions the dispensing of medication by a pharmacist and the availability of a medication guide for patients. More details can be found on the website mentioned at the end of the text.*
FDA Label Image

100 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 05)

100 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 05)
This text mentions a medication called Brivaracetam in the form of tablets. It indicates that the tablets contain FD&C Yellow No. 5 (tartrazine) and provides instructions for storage at a temperature range of 20°C to 25°C. The packaging is child-resistant and it advises to keep all drugs out of reach of children. The medication should be dispensed by a pharmacist, and a medication guide is provided separately to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.